Qiagen NV Market Cap ($7.79 Billion)
Market Cap & Net Worth: Qiagen NV (QGEN)
Qiagen NV market cap. Qiagen NV (NYSE:QGEN) has a market capitalization of $7.79 Billion ($7.79 Billion) as of November 6, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #2587 globally and #948 in its home market, demonstrating a 1.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Qiagen NV's stock price $50.86 by its total outstanding shares 206250000 (206.25 Million). Also see Qiagen NV cash flow conversion for how efficiently the company converts equity into cash flow.
Qiagen NV Market Cap History (2015–2026)
Qiagen NV market cap history from 2015 to 2026. Data shows growth from $5.71 Billion to $10.49 Billion (6.38% CAGR). Check QGEN stock price and chart for real-time trading data and today's change.
Qiagen NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Qiagen NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Qiagen NV annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.44x
Qiagen NV's market cap is 4.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.83x
Qiagen NV's market cap is 21.83 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.78 Billion | $1.34 Billion | $80.40 Million | 4.32x | 71.94x |
| 2017 | $6.38 Billion | $1.42 Billion | $40.39 Million | 4.50x | 158.05x |
| 2018 | $7.11 Billion | $1.50 Billion | $190.38 Million | 4.73x | 37.35x |
| 2019 | $6.98 Billion | $1.53 Billion | -$41.45 Million | 4.57x | N/A |
| 2020 | $10.91 Billion | $1.87 Billion | $359.19 Million | 5.83x | 30.37x |
| 2021 | $11.47 Billion | $2.25 Billion | $512.60 Million | 5.10x | 22.38x |
| 2022 | $10.29 Billion | $2.14 Billion | $423.21 Million | 4.81x | 24.32x |
| 2023 | $8.96 Billion | $1.97 Billion | $341.30 Million | 4.56x | 26.27x |
| 2024 | $9.18 Billion | $1.98 Billion | $83.59 Million | 4.64x | 109.87x |
| 2025 | $9.28 Billion | $2.09 Billion | $424.88 Million | 4.44x | 21.83x |
Competitor Companies of QGEN by Market Capitalization
Companies near Qiagen NV in the global market cap rankings as of November 6, 2026. Also see Qiagen NV (QGEN) total assets for a full breakdown of the balance sheet.
Key companies related to Qiagen NV by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #146 globally with a market cap of $159.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #478 globally with a market cap of $55.90 Billion USD ( CN¥382.02 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #510 globally with a market cap of $52.43 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $676.94 |
| #146 | Danaher Corporation | NYSE:DHR | $159.88 Billion | $226.34 |
| #478 | WuXi AppTec Co Ltd | SHG:603259 | $55.90 Billion | CN¥154.46 |
| #510 | Natera Inc | NASDAQ:NTRA | $52.43 Billion | $363.76 |
Market Capitalization of Qiagen NV (2015–2026)
Market capitalization of Qiagen NV from 2015 to today. Between 2015 and today, Qiagen NV's market cap moved from $5.71 Billion to $ 10.49 Billion, with a yearly change of 6.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $10.49 Billion | +13.10% |
| 2025 | $9.28 Billion | +0.99% |
| 2024 | $9.18 Billion | +2.45% |
| 2023 | $8.96 Billion | -12.91% |
| 2022 | $10.29 Billion | -10.27% |
| 2021 | $11.47 Billion | +5.17% |
| 2020 | $10.91 Billion | +56.36% |
| 2019 | $6.98 Billion | -1.89% |
| 2018 | $7.11 Billion | +11.38% |
| 2017 | $6.38 Billion | +10.38% |
| 2016 | $5.78 Billion | +1.34% |
| 2015 | $5.71 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Qiagen NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.79 Billion USD |
| MoneyControl | $7.79 Billion USD |
| MarketWatch | $7.79 Billion USD |
| marketcap.company | $7.79 Billion USD |
| Reuters | $7.79 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Qiagen NV
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technol… Read more